|
1
|
Crippa S, Fernández-Del CC, Salvia R, et
al: Mucin-producing neoplasms of the pancreas: an analysis of
distinguishing clinical and epidemiologic characteristics. Clin
Gastroenterol Hepatol. 8:213–219. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Testini M, Gurrado A, Lissidini G, Venezia
P, Greco L and Piccinni G: Management of mucinous cystic neoplasms
of the pancreas. World J Gastroenterol. 16:5682–5692. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Grogan JR, Saeian K, Taylor AJ, Quiroz F,
Demeure MJ and Komorowski RA: Making sense of mucin-producing
pancreatic tumors. AJR Am J Roentgenol. 176:921–929. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Crippa S, Salvia R, Warshaw AL, et al:
Mucinous cystic neoplasm of the pancreas is not an aggressive
entity: lessons from 163 resected patients. Ann Surg. 247:571–579.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Matthaei H, Schulick RD, Hruban RH and
Maitra A: Cystic precursors to invasive pancreatic cancer. Nat Rev
Gastroenterol Hepatol. 8:141–50. 2011. View Article : Google Scholar
|
|
6
|
Goh BK, Tan YM, Chung YF, et al: A review
of mucinous cystic neoplasms of the pancreas defined by
ovarian-type stroma: clinicopathological features of 344 patients.
World J Surg. 30:2236–2245. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sawhney MS, Devarajan S, O’Farrel P, et
al: Comparison of carcinoembryonic antigen and molecular analysis
in pancreatic cyst fluid. Gastrointest Endosc. 69:1106–1110. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bloomston M, Frankel WL, Petrocca F, et
al: MicroRNA expression patterns to differentiate pancreatic
adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA.
297:1901–1908. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Szafranska AE, Doleshal M, Edmunds HS, et
al: Analysis of microRNAs in pancreatic fine-needle aspirates can
classify benign and malignant tissues. Clin Chem. 54:1716–1724.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yu J, Li A, Hong SM, Hruban RH and Goggins
M: MicroRNA alterations of pancreatic intraepithelial neoplasias.
Clin Cancer Res. 18:981–992. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Remmers N, Bailey JM, Mohr AM and
Hollingsworth MA: Molecular pathology of early pancreatic cancer.
Cancer Biomark. 9:421–440. 2011.
|
|
12
|
du Rieu MC, Torrisani J, Selves J, et al:
MicroRNA-21 is induced early in pancreatic ductal adenocarcinoma
precursor lesions. Clin Chem. 56:603–612. 2010.
|
|
13
|
Jamieson NB, Morran DC, Morton JP, et al:
MicroRNA molecular profiles associated with diagnosis,
clinicopathologic criteria, and overall survival in patients with
resectable pancreatic ductal adenocarcinoma. Clin Cancer Res.
18:534–545. 2012. View Article : Google Scholar
|
|
14
|
Habbe N, Koorstra JB, Mendell JT, et al:
MicroRNA miR-155 is a biomarker of early pancreatic neoplasia.
Cancer Biol Ther. 8:340–346. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Fukushima N, Sato N, Prasad N, Leach SD,
Hruban RH and Goggins M: Characterization of gene expression in
mucinous cystic neoplasms of the pancreas using oligonucleotide
microarrays. Oncogene. 23:9042–9051. 2004. View Article : Google Scholar
|
|
16
|
Yao G, Yin M, Lian J, et al: MicroRNA-224
is involved in transforming growth factor-beta-mediated mouse
granulosa cell proliferation and granulosa cell function by
targeting Smad4. Mol Endocrinol. 24:540–551. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Izeradjene K, Combs C, Best M, et al:
Kras(G12D) and Smad4/Dpc4 haploinsufficiency cooperate to induce
mucinous cystic neoplasms and invasive adenocarcinoma of the
pancreas. Cancer Cell. 11:229–243. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mees ST, Mardin WA, Sielker S, et al:
Involvement of CD40 targeting miR-224 and miR-486 on the
progression of pancreatic ductal adenocarcinomas. Ann Surg Oncol.
16:2339–2250. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Rodilla V, Villanueva A, Obrador-Hevia A,
et al: Jag1 is the pathological link between Wnt and Notch pathways
in colorectal cancer. Proc Natl Acad Sci USA. 106:6315–6320. 2009.
View Article : Google Scholar
|
|
20
|
Kiefel H, Bondong S, Erbe-Hoffmann N, et
al: L1CAM-integrin interaction induces constitutive NF-kappaB
activation in pancreatic adenocarcinoma cells by enhancing IL-1beta
expression. Oncogene. 29:4766–4778. 2010. View Article : Google Scholar
|
|
21
|
Levy L and Hill CS: Smad4 dependency
defines two classes of transforming growth factor {beta}
(TGF-{beta}) target genes and distinguishes TGF-{beta}-induced
epithelial-mesenchymal transition from its antiproliferative and
migratory responses. Mol Cell Biol. 25:8108–8125. 2005. View Article : Google Scholar
|
|
22
|
Maniati E, Bossard M, Cook N, et al:
Crosstalk between the canonical NF-κB and Notch signaling pathways
inhibits Pparγ expression and promotes pancreatic cancer
progression in mice. J Clin Invest. 121:4685–4699. 2011.
|
|
23
|
Wang Z, Banerjee S, Ahmad A, et al:
Activated K-ras and INK4a/Arf deficiency cooperate during the
development of pancreatic cancer by activation of Notch and NF-κB
signaling pathways. PLoS One. 6:e205372011.PubMed/NCBI
|
|
24
|
Bao B, Wang Z, Ali S, et al: Notch-1
induces epithelial-mesenchymal transition consistent with cancer
stem cell phenotype in pancreatic cancer cells. Cancer Lett.
307:26–36. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Vaccaro V, Melisi D, Bria E, et al:
Emerging pathways and future targets for the molecular therapy of
pancreatic cancer. Expert Opin Ther Targets. 15:1183–1196. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Prueitt RL, Yi M, Hudson RS, et al:
Expression of microRNAs and protein-coding genes associated with
perineural invasion in prostate cancer. Prostate. 68:1152–1164.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Davalos V, Moutinho C, Villanueva A, et
al: Dynamic epigenetic regulation of the microRNA-200 family
mediates epithelial and mesenchymal transitions in human
tumorigenesis. Oncogene. 31:2062–2074. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sorio C, Capelli P, Lissandrini D, et al:
Mucinous cystic carcinoma of the pancreas: a unique cell line and
xenograft model of a preinvasive lesion. Virchows Arch.
446:239–245. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Katoh M and Katoh M: Notch ligand, JAG1,
is evolutionarily conserved target of canonical WNT signaling
pathway in progenitor cells. Int J Mol Med. 17:681–685.
2006.PubMed/NCBI
|
|
30
|
Selcuklu SD, Donoghue MT, Kerin MJ and
Spillane C: Regulatory interplay between miR-21, JAG1 and
17beta-estradiol (E2) in breast cancer cells. Biochem Biophys Res
Commun. 423:234–239. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Pang RT, Leung CO, Ye TM, et al:
MicroRNA-34a suppresses invasion through downregulation of Notch1
and Jag1 in cervical carcinoma and choriocarcinoma cells.
Carcinogenesis. 31:1037–1044. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Steg AD, Katre AA, Goodman B, et al:
Targeting the notch ligand JAGGED1 in both tumor cells and stroma
in ovarian cancer. Clin Cancer Res. 17:5674–5685. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Brabletz S, Bajdak K, Meidhof S, et al:
The ZEB1/miR-200 feedback loop controls Notch signalling in cancer
cells. EMBO J. 30:770–782. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ban J, Bennani-Baiti IM, Kauer M, et al:
EWS-FLI1 suppresses NOTCH-activated p53 in Ewing’s sarcoma. Cancer
Res. 68:7100–7109. 2008.PubMed/NCBI
|
|
35
|
Sasaki Y, Ishida S, Morimoto I, et al: The
p53 family member genes are involved in the Notch signal pathway. J
Biol Chem. 277:719–724. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Dickson BC, Mulligan AM, Zhang H, et al:
High-level JAG1 mRNA and protein predict poor outcome in breast
cancer. Mod Pathol. 20:685–693. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Golson ML, Le Lay J, Gao N, et al: Jag1 is
a competitive inhibitor of Notch signaling in the embryonic
pancreas. Mech Dev. 126:687–699. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Bao B, Wang Z, Ali S, et al: Notch-1
induces epithelial-mesenchymal transition consistent with cancer
stem cell phenotype in pancreatic cancer cells. Cancer Lett.
307:26–36. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Golson ML, Loomes KM, Oakey R and Kaestner
KH: Ductal malformation and pancreatitis in mice caused by
conditional Jag1 deletion. Gastroenterology. 136:1761–1771. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Fukushima N, Sato N, Prasad N, Leach SD,
Hruban RH and Goggins M: Characterization of gene expression in
mucinous cystic neoplasms of the pancreas using oligonucleotide
microarrays. Oncogene. 23:9042–9051. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Tan MH, Nowak NJ, Loor R, et al:
Characterization of a new primary human pancreatic tumor line.
Cancer Invest. 4:15–23. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Volinia S, Calin GA, Liu CG, et al: A
microRNA expression signature of human solid tumors defines cancer
gene targets. Proc Natl Acad sci USA. 103:2257–2261. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zhang S, Hao J, Xie F, Hu X, et al:
Downregulation of miR-132 by promoter methylation contributes to
pancreatic cancer development. Carcinogenesis. 32:1183–1189. 2011.
View Article : Google Scholar : PubMed/NCBI
|
